Avidian Wealth Enterprises’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.89M | Buy |
35,331
+1,813
| +5% | +$390K | 0.25% | 69 |
|
|
2026
Q1 | $7.29M | Buy |
33,518
+15,125
| +82% | +$3.36M | 0.23% | 72 |
|
|
2025
Q4 | $4.2M | Buy |
18,393
+1,258
| +7% | +$287K | 0.15% | 90 |
|
|
2025
Q3 | $3.97M | Buy |
17,135
+1,158
| +7% | +$236K | 0.15% | 93 |
|
|
2025
Q2 | $2.97M | Sell |
15,977
-1,030
| -6% | -$191K | 0.12% | 95 |
|
|
2025
Q1 | $3.56M | Buy |
17,007
+709
| +4% | +$138K | 0.16% | 87 |
|
|
2024
Q4 | $2.9M | Buy |
16,298
+276
| +2% | +$50.7K | 0.13% | 96 |
|
|
2024
Q3 | $3.16M | Buy |
16,022
+353
| +2% | +$65.9K | 0.14% | 88 |
|
|
2024
Q2 | $2.69M | Buy |
15,669
+578
| +4% | +$95.7K | 0.11% | 99 |
|
|
2024
Q1 | $2.75M | Buy |
15,091
+734
| +5% | +$127K | 0.13% | 88 |
|
|
2023
Q4 | $2.22M | Buy |
14,357
+564
| +4% | +$82.2K | 0.14% | 101 |
|
|
2023
Q3 | $2.06M | Sell |
13,793
-1,275
| -8% | -$187K | 0.14% | 97 |
|
|
2023
Q2 | $2.03M | Sell |
15,068
-25,030
| -62% | -$3.67M | 0.13% | 112 |
|
|
2023
Q1 | $6.39M | Buy |
40,098
+2,805
| +8% | +$429K | 0.35% | 64 |
|
|
2022
Q4 | $6.03M | Buy |
37,293
+589
| +2% | +$90.3K | 0.39% | 53 |
|
|
2022
Q3 | $4.93M | Buy |
36,704
+3,043
| +9% | +$437K | 0.36% | 54 |
|
|
2022
Q2 | $5.16M | Sell |
33,661
-2,326
| -6% | -$355K | 0.36% | 55 |
|
|
2022
Q1 | $5.83M | Buy |
35,987
+345
| +1% | +$50.1K | 0.36% | 54 |
|
|
2021
Q4 | $4.83M | Buy |
35,642
+2,097
| +6% | +$248K | 0.3% | 65 |
|
|
2021
Q3 | $3.62M | Buy |
33,545
+2,171
| +7% | +$248K | 0.28% | 61 |
|
|
2021
Q2 | $3.53M | Buy |
31,374
+1,081
| +4% | +$122K | 0.27% | 61 |
|
|
2021
Q1 | $3.28M | Buy |
30,293
+209
| +0.7% | +$22.4K | 0.28% | 61 |
|
|
2020
Q4 | $3.22M | Buy |
30,084
+4,351
| +17% | +$418K | 0.31% | 54 |
|
|
2020
Q3 | $2.25M | Buy |
25,733
+3,786
| +17% | +$356K | 0.26% | 60 |
|
|
2020
Q2 | $2.15M | Buy |
21,947
+2,193
| +11% | +$193K | 0.29% | 58 |
|
|
2020
Q1 | $1.5M | Buy |
19,754
+7,934
| +67% | +$676K | 0.24% | 51 |
|
|
2019
Q4 | $1.05M | Buy |
11,820
+149
| +1% | +$12.4K | 0.15% | 64 |
|
|
2019
Q3 | $884K | Buy |
11,671
+36
| +0.3% | +$2.47K | 0.15% | 63 |
|
|
2019
Q2 | $846K | Buy |
11,635
+923
| +9% | +$72.5K | 0.2% | 45 |
|
|
2019
Q1 | $863K | Buy |
10,712
+1,038
| +11% | +$84.9K | 0.19% | 44 |
|
|
2018
Q4 | $892K | Buy |
9,674
+6,017
| +165% | +$529K | 0.31% | 35 |
|
|
2018
Q3 | $346K | Sell |
3,657
-1,763
| -33% | -$167K | 0.11% | 73 |
|
|
2018
Q2 | $502K | Sell |
5,420
-400
| -7% | -$39.1K | 0.16% | 54 |
|
|
2018
Q1 | $551K | Hold |
5,820
| – | – | 0.18% | 47 |
|
|
2017
Q4 | $563 | Hold |
5,820
| – | – | 0.15% | 45 |
|
|
2017
Q3 | $517K | Buy |
5,820
+584
| +11% | +$44.5K | 0.2% | 42 |
|
|
2017
Q2 | $380K | Buy |
5,236
+116
| +2% | +$7.8K | 0.16% | 51 |
|
|
2017
Q1 | $334K | Buy |
+5,120
| New | +$322K | 0.13% | 57 |
|
Other funds holding ABBV
Avidian Wealth Enterprises's ABBV Position: Q2 2026 in Review
Avidian Wealth Enterprises increased its AbbVie (ABBV) stake by 5.4% in Q2 2026, buying an estimated $390K and bringing the position to 35,331 shares worth $8.89M. The position accounts for 0.25% of the portfolio, ranked #69.
Avidian Wealth Enterprises first reported a position in ABBV in Q1 2017 and has held it in 38 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Avidian Wealth Enterprises held 35,331 shares of AbbVie worth $8.89M as of Q2 2026.
- Avidian Wealth Enterprises bought 1,813 AbbVie shares in Q2 2026, an estimated $390K.
- AbbVie made up 0.25% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #69 holding.
- Avidian Wealth Enterprises first reported a position in AbbVie in Q1 2017 and has held it in 38 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.